Generate Biomedicines Picks First Targets To Test Its AI-Based Drug Discovery Revolution
Mutation-Resistant COVID-19 Therapy Is First Candidate
Built with an audacious goal to use AI to unlock the secrets of protein structure and function, Generate Biomedicines believes it is now on the cusp of a drug discovery revolution.
